TD Securities upgraded Extendicare (EXETF) to Buy from Hold with a C$32 price target
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EXETF:
- Extendicare’s ParaMed Closes $570 Million Acquisition of CBI Home Health
- Extendicare refreshes board as it deepens shift to health services
- Extendicare Declares March 2026 Dividend, Signals Confidence in Senior-Care Operations
- Extendicare price target raised to C$30 from C$25 at RBC Capital
- Extendicare Inc. Showcases Strong Growth in Earnings Call